NIMES, France--(BUSINESS WIRE)--Proteus today announced the completion of a share capital increase reserved for Protéus’ industrial partner PCAS. PCAS’ stake in Protéus now represents 32% of the issued share capital vs 6% before the increase. Proceeds of this private placement are to be used to accelerate the growth of PROTEUS’ PSI and PCAS BIOSOLUTION businesses.
